Stoke Therapeutics ROA Ratio 2011-2026 | STOK

Annual ROA Ratio Stoke Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-45.85	-39.47	-35.92	-17.54	-14.13	-11.64	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-11.64	-45.85	-27.43

Quarterly ROA Ratio Stoke Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.98	3.61	1.37	-30.21	-40.44	-41.66	-45.25	-30.16	-39.57	-38.74	-34.99	-25.39	-34.29	-33.79	-33.92	-23.23	-28.12	-23.81	-19.85	-17.54	-17.09	-16.26	-15.33	-14.13	-13.67	-12.99	-12.38	-9.87	-5.88	-2.8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3.61	-45.25	-21.81

ROA Ratio of other stocks in the Biotechnology industry

Issuer	ROA Ratio	Price	% 24h	Market Cap	Country
Acer Therapeutics ACER	-225.71	-	2.71 %	$ 14 M	USA
MorphoSys AG MOR	-20.13	-	2.43 %	$ 254 M	Germany
Adverum Biotechnologies ADVM	-72.8	-	-	$ 86.2 M	USA
Acasti Pharma ACST	-13.29	-	4.01 %	$ 150 M	Canada
I-Mab IMAB	7.43	-	-	$ 866 M	China
Applied Genetic Technologies Corporation AGTC	-27.57	-	-	$ 26.5 M	USA
Aptorum Group Limited APM	-26.46	$ 0.84	2.78 %	$ 4.58 M	China
Alexion Pharmaceuticals, Inc. ALXN	3.33	-	-	$ 40.3 B	USA
Adagene ADAG	-37.44	$ 2.95	10.3 %	$ 166 M	China
Biophytis SA BPTS	-89.6	-	-13.47 %	$ 169 M	France
AlloVir ALVR	-49.57	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	-150.49	-	-11.43 %	$ 502 K	USA
Midatech Pharma plc MTP	-42.28	-	-18.52 %	$ 27.3 M	Britain
Amarin Corporation plc AMRN	-7.11	$ 15.08	2.24 %	$ 6.15 B	Irlanda
EyeGate Pharmaceuticals, Inc. EYEG	-53.39	-	-1.52 %	$ 24.7 M	USA
Alterity Therapeutics Limited ATHE	-31.06	$ 3.51	-1.68 %	$ 8.45 B	Australia
Applied Molecular Transport AMTI	-117.57	-	-	$ 10.1 M	USA
ARCA biopharma ABIO	-21.14	-	1052.0 %	$ 415 M	USA
Aptose Biosciences APTO	-251.11	-	-45.71 %	$ 1.2 M	Canada
Acorda Therapeutics ACOR	-232.99	-	-24.86 %	$ 820 K	USA
Athira Pharma ATHA	-164.92	-	-	$ 269 M	USA
Akero Therapeutics AKRO	-30.52	-	-	$ 3.67 B	USA
Aeglea BioTherapeutics AGLE	-34.19	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	-11.27	-	-0.23 %	$ 916 M	USA
Brickell Biotech BBI	-49.15	-	-5.38 %	$ 6.06 M	USA
Институт стволовых клеток человека ISKJ	4.82	-	-	-	Russia
Allena Pharmaceuticals ALNA	-140.01	-	3.16 %	$ 1.9 M	USA
Ascendis Pharma A/S ASND	-35.36	$ 222.25	0.1 %	$ 5 B	Danmark
Aptinyx APTX	-97.25	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	-122.8	-	-13.39 %	$ 1.45 M	USA
BioNTech SE BNTX	65.02	$ 109.88	-0.42 %	$ 27.2 B	Germany
Arena Pharmaceuticals ARNA	-78.56	-	-6.81 %	$ 3.04 B	USA
BeiGene, Ltd. BGNE	-10.89	-	0.49 %	$ 251 B	Cayman-islands
Aridis Pharmaceuticals ARDS	-206.68	-	17.91 %	$ 11.1 M	USA
Burford Capital Limited BUR	5.51	$ 9.21	2.56 %	$ 1.48 B	Britain
Aeterna Zentaris AEZS	-10.45	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-123.72	-	-10.17 %	$ 12.2 K	USA
Athersys ATHX	-144.48	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	-31.09	-	0.23 %	$ 488 M	USA
Avenue Therapeutics ATXI	-437.72	-	-52.27 %	$ 4.45 M	USA
Baudax Bio BXRX	-586.07	-	0.59 %	$ 63 K	USA
Cabaletta Bio CABA	-26.68	$ 2.64	7.99 %	$ 3.08 M	USA
Can-Fite BioPharma Ltd. CANF	-86.4	$ 4.4	2.8 %	$ 9.57 B	Israel
Calithera Biosciences CALA	-177.73	-	-10.95 %	$ 876 K	USA
Autolus Therapeutics plc AUTL	-28.19	$ 1.44	-1.37 %	$ 367 M	Britain
Amneal Pharmaceuticals AMRX	-2.11	$ 14.79	1.83 %	$ 4.57 B	USA
AIkido Pharma AIKI	-31.2	-	1.93 %	$ 17.4 M	USA
AVROBIO AVRO	12.03	-	1083.1 %	$ 745 M	USA
CureVac N.V. CVAC	-35.55	-	-	$ 867 M	Germany
Alpine Immune Sciences ALPN	-20.15	-	-	$ 2.17 B	USA